Skip to main content
. 2021 Sep 16;7(11):1–10. doi: 10.1001/jamaoncol.2021.3690

Figure 3. Kaplan-Meier Plots of Event-Free Survival (EFS) in Hormone Receptor (HR)–Positive/ERBB2-Negative, HR-Negative/ERBB2-Negative, HR-Positive/ERBB2-Positive, and HR-Negative/ERBB2-Positive Subtypes.

Figure 3.

pCR indicates pathologic complete response; RCB, residual cancer burden.